Posted: June 9, 2023 at 4:51 PM ET
Healthcare firms rose as traders bet that the sector would see a pickup in growth.
Drug giants including drugmakers Teva and Allergan, and pharmacy chains CVS and Walgreen, have completed a deal to pay $19 billion to states that have accused them of fueling the opioid crisis, and pour more money into communities still struggling to tackle the scourge of drug use.
the…
Healthcare firms rose as traders bet that the sector would see a pickup in growth.
Drug giants including drugmakers Teva and Allergan, and pharmacy chains CVS and Walgreen, have completed a deal to pay $19 billion to states that have accused them of fueling the opioid crisis, and pour more money into communities still struggling to tackle the scourge of drug use.
The agreement comes on top of a so-called $26 billion global settlement with drug distributors McKesson, Cardinal Health, AmerisourceBergen and manufacturer Johnson & Johnson.
The committee meeting where FDA advisors will make a recommendation on Biogen’s Leqembi and Eisai’s Alzheimer’s drug, Salim Syed and Eric Lavington, analysts at Mizuho, say in a research note, in a research note.
Write to Rob Curran at rob.curran@dowjones.com
[ad_2]